Skip to main content

Table 4 Number of drug targets in top 1, 5, 10, 15 and 20 % of the essential non-homologous proteins

From: Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network

Non-homologous Essential proteins Number of validated drug targets
1 %(5) 2
5 %(26) 4
10 %(53) 13
15 %(80) 21
20 %(107) 21